Trending...
- The Story of John Finding a Pair of Sunglasses That Comfortably Fit His Watermelon Size Head
- New Rochelle: North Ave Bridge - UPDATE
- Phuoc Vu Releases Book One In His Origins, Curse Borne Out of Love Series
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Near-Term Launches + High-Value Pipeline Day on Monday, December 12, 2022 from 1:00 p.m. EST to 6:00 p.m. EST, with an approximately 30 minute break at the midpoint. Pfizer business executives and scientific leadership will provide updates on the company's potential near-term product launches and key high-value pipeline programs, both of which are expected to be primary growth drivers for Pfizer's 2030 revenues and beyond.
To access the live webcast and presentation slides, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance.
Participants will also have an opportunity to submit questions via the webcast and selected questions will be asked during the live Q&A sessions with leadership.
Participants who are unable to join the webcast from a computer or mobile device can dial either (800) 456-4352 in the United States and Canada or (785) 424-1086 outside of the United States and Canada. The passcode is "12304". This audio line is a "listen only" experience and questions cannot be submitted through the audio line.
The transcript and webcast replay will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live webcast and will be accessible for at least 90 days.
More on Nyenta.com
About Pfizer: Breakthroughs That Change Patients' Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
More on Nyenta.com
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated future operating and financial performance; reorganizations; business plans, strategy and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, growth, performance, timing of exclusivity and potential benefits; strategic reviews, capital allocation objectives, dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; our ability to successfully capitalize on growth opportunities and prospects; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned "Risk Factors" and "Forward-Looking Information and Factors That May Affect Future Results", as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance, Research, Medicines, Vaccines
Contacts
Media:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor:
IR@Pfizer.com
+1 (212) 733-4848
To access the live webcast and presentation slides, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance.
Participants will also have an opportunity to submit questions via the webcast and selected questions will be asked during the live Q&A sessions with leadership.
Participants who are unable to join the webcast from a computer or mobile device can dial either (800) 456-4352 in the United States and Canada or (785) 424-1086 outside of the United States and Canada. The passcode is "12304". This audio line is a "listen only" experience and questions cannot be submitted through the audio line.
The transcript and webcast replay will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live webcast and will be accessible for at least 90 days.
More on Nyenta.com
- New "Learning Lab" Format Revolutionizes Sensual Bachata and Acroyoga Classes in NYC
- SILVERGATE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Silvergate To Contact Him Directly To Discuss Their Options
- 3DMyRental Launches Professional 3D Floor Plan Services for Airbnb Hosts: A Game-Changing Solution for Property Rentals
- Best Online End-Of-Season Clearance Sale at Sunber Hair: $56 For A Lace Wig
- UNice Hair Partners With Awin Affiliate Marketing Network To Accelerate Business Growth
About Pfizer: Breakthroughs That Change Patients' Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
More on Nyenta.com
- automotiveMastermind Integrates with DealerSocket to Improve Efficiency for Dealership Sales Teams
- Rochester: Statement from Mayor Malik D. Evans and Police Chief David Smith Regarding Body Worn Camera Footage from Memphis, Tenn.
- BIOVENTUS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options
- Archivirex Set to Release Highly Anticipated EDM Album Titled "Neon Purple Dusk"
- GENERAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Generac Holdings, Inc. and Encourages Investors to Contact the Firm
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated future operating and financial performance; reorganizations; business plans, strategy and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, growth, performance, timing of exclusivity and potential benefits; strategic reviews, capital allocation objectives, dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; our ability to successfully capitalize on growth opportunities and prospects; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned "Risk Factors" and "Forward-Looking Information and Factors That May Affect Future Results", as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance, Research, Medicines, Vaccines
Contacts
Media:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor:
IR@Pfizer.com
+1 (212) 733-4848
Filed Under: Business
0 Comments
Latest on Nyenta.com
- Flawless Torres ft. Diamonique x Sean Kingston Releases "Lets Go" on 1/27/23!
- Blackstone Secured Lending Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
- RADIPLY RISING RADIO STATION "POWER RADIO NATION" IS HELPING BUSINESSES THRIVE IN 2023! USA - English USA - English USA - English
- We're In Paris Is Sidow Sobrino's Newly Released Song and Video
- Rochester: Motorist Advisory - Corinthian St. Downtown to Close Saturday and Sunday
- ESS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ESS Tech, Inc. and Encourages Investors to Contact the Firm
- PROG SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PROG To Contact Him Directly To Discuss Their Options
- BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution
- Abusive Russian to face Pro Wrestling Legend!
- Goldman Sachs x Robin Hood Inaugural Rising Leaders Forum Attracts Nearly 300 Young Investors to Chart Philanthropic Impact
- Jim Wilson, Top Notch Realtor in waterfront and beach properties in Redington, Redington Shores, and North Redington Beach, FLorida
- New Rochelle: Resident Input Wanted on Affordable Housing and Community Development Priorities
- Multi #1 International Best-Selling Author Jennifer S. Wilkov Announces the 2023 April Speak Up Women Conference and Call For Speakers
- Equinor and bp Bid for Third New York Offshore Wind Solicitation
- SEC EDGAR Form 13F Filing - Cost-effective Easy-to-use Self-Service Web Portal for Investment Managers and Financial Advisors
- ROSEN, LEADING TRIAL ATTORNEYS, Encourages Gaia, Inc. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm - GAIA
- The BuildESG Membership Expands Features to Include Benchmarking of Private Equity and Venture Capital Firms' ESG Programs
- Cascade Asset Management Releases its 9th Annual IT Asset Disposition Benchmarking Report
- New AI Tool Makes Speedy Gene-Editing Possible
- New Rochelle: Paper Collection Reminder